View Older Stories View More Recent Stories

May 22, 2023 11:02AM Precipio's (PRPO) Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology
May 22, 2023 11:00AM Precipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology
May 17, 2023 04:00PM Precipio (PRPO) Shares Growth Catalysts For HemeScreen
May 17, 2023 04:00PM Precipio Shares Growth Catalysts For HemeScreen
May 15, 2023 04:00PM Precipio Announces Q1-2023 Shareholder Update Call
May 4, 2023 01:00PM Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division
May 4, 2023 10:00AM Precipio Signs Another HemeScreen™ Customer
Apr 27, 2023 05:00PM Precipio (PRPO) Granted 180-day Extension From NASDAQ To Regain Compliance
Apr 27, 2023 05:00PM Precipio Granted 180-day Extension From NASDAQ To Regain Compliance
Apr 19, 2023 11:00AM Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined
Mar 28, 2023 05:00PM Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call
Mar 21, 2023 10:30AM Precipio Ships First IV-Cell® Order to Major US Healthcare System
Mar 7, 2023 12:49PM CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customers
Mar 7, 2023 12:01PM Precipio (PRPO) continues to sign up and onboard HemeScreen customers
Mar 7, 2023 12:00PM Precipio continues to sign up and onboard HemeScreen™ customers
Feb 14, 2023 11:44AM ThermoFisher Salesforce Votes Precipio’s HemeScreen® as “Best New Product”
Jan 11, 2023 10:00AM Precipio Signs Another Major HemeScreen™ Customer
Dec 6, 2022 10:01AM Precipio (PRPO) Signs Additional Major HemeScreen Customer
Dec 6, 2022 10:00AM Precipio Signs Additional Major HemeScreen™ Customer
Nov 7, 2022 10:30AM Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference
Nov 2, 2022 05:00PM Precipio Announces Third Quarter Shareholder Update Call
Sep 15, 2022 11:01AM Precipio (PRPO) Enters Agreement with Another Major US Healthcare Distributor for HemeScreen
Sep 15, 2022 11:00AM Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™
Aug 24, 2022 11:00AM Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales
Aug 16, 2022 11:00AM Precipio Launches New 1-Step Technology for all HemeScreen Assays
Aug 10, 2022 10:00AM Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development
Aug 8, 2022 10:00AM Precipio Announces Second Quarter Shareholder Update Call
Jul 20, 2022 10:30AM Precipio to distribute HemeScreen® through Fisher Healthcare channel
Jun 14, 2022 02:00PM Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote
Jun 13, 2022 11:00AM Keith Meadors Joins Precipio to Lead its Products Division
May 24, 2022 10:31AM Precipio (PRPO) Receives CE-IVD Certification to Market Multiple HemeScreen Panels in Europe
May 24, 2022 10:30AM Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe
May 10, 2022 10:30AM Precipio Signs First IV-Cell Customer Agreement
Apr 26, 2022 10:00AM Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
Mar 22, 2022 06:00PM Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call
Mar 21, 2022 05:00PM Precipio (PRPO) Announces CFO Resignation, Appoints Matt Gage as Interim CFO
Mar 21, 2022 05:00PM Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO
Feb 24, 2022 10:00AM Precipio (PRPO) Reports Prelim 2021 Revenue of $8.9M
Feb 24, 2022 10:00AM Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
Nov 18, 2021 10:00AM New York State Approves Precipio’s HemeScreen for POL clinical use
Nov 1, 2021 05:00PM Precipio Announces Q3-2021 and year-end Shareholder Update Call
Aug 26, 2021 10:00AM American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
Aug 20, 2021 05:00PM Precipio Reschedules Q2-2021 Shareholder Update Call
Aug 13, 2021 10:48AM Precipio Corrects Announcement of Q2-2021 Shareholder Update Call
Aug 12, 2021 05:00PM Precipio Announces Q2-2021 and year-end Shareholder Update Call
Jul 28, 2021 10:00AM Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
Jun 15, 2021 11:01AM Precipio (PRPO) Terminates its Equity Line
Jun 15, 2021 11:00AM Precipio Terminates its Equity Line
Jun 8, 2021 10:30AM Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
May 14, 2021 04:30PM Precipio Announces Q1-2021 and year-end Shareholder Update Call
View More Recent Stories View Older Stories